Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
NCT05059587
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
318
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
MBA-P01
DRUG:
BOTOX
Sponsor
Medytox Korea